Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone vs Gliclazide in T2DM with Angina
NCT00225342Phase 4Withdrawn
- Sponsor
- University of Glasgow
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in angina pectoris, type 2 diabetes mellitus (T2DM), sponsored by University of Glasgow. Status: withdrawn.
02
Drugs
rosiglitazone
03
Conditions
angina pectoristype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00225342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225342.